Gene: LRRC17
Official Full Name: leucine rich repeat containing 17provided by HGNC
Gene Summary: Predicted to be involved in bone marrow development and negative regulation of osteoclast differentiation. Predicted to be located in extracellular region. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32101 | LRRC17 Knockout cell line (HEK293) | Human | LRRC17 | 1:3~1:6 | Negative | Online Inquiry |
LRRC17 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the in-depth study of the leucine-rich repeat-containing protein 17 (LRRC17) and its role in physiological and pathological processes. The knockout of the LRRC17 gene results in the complete abrogation of protein expression, allowing researchers to investigate the biological implications of LRRC17 deficiency and its potential involvement in various cellular pathways.
These cell lines function by employing targeted genome editing technologies such as CRISPR/Cas9, which creates specific and heritable mutations within the LRRC17 locus. By removing this gene, researchers can elucidate the subsequent effects on cellular behavior, signaling pathways, and overall cellular functions, making these cell lines invaluable for studies in cancer biology, neurobiology, and developmental biology.
Scientifically, LRRC17 Gene Knockout Cell Lines are an important tool for understanding diseases where LRRC17 play a contributory role, potentially aiding in the identification of novel therapeutic targets. Their applications stretch across academic research, drug discovery, and development, providing critical insights that could translate into clinical innovations.
The unique selling point of these cell lines lies in their specificity and reliability. Unlike traditional methods of gene silencing, such as RNA interference, which may result in temporary and off-target effects, the knockout approach ensures a permanent and precise removal of the LRRC17 gene. This makes the cell lines a gold standard for researchers requiring definitive insights into LRRC17 function.
In conclusion, our LRRC17 Gene Knockout Cell Lines are a testament to our commitment to providing high-quality, cutting-edge biological tools for the scientific community. With a robust support system and expertise in the development of advanced genomic models, we empower researchers and clinicians to advance their discoveries and enhance their exploratory capabilities.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.